Evidence map›Paper›PMID 40329359›Full record

SynthesisCritical care (London, England)2025

Early norepinephrine for patients with septic shock: an updated systematic review and meta-analysis with trial sequential analysis.

Rui Shi, Rayan Braïk, Xavier Monnet, Wan-Jie Gu, Gustavo Ospina-Tascon, Chairat Permpikul, Maxime Djebbour, Alice Soumare, Vincent Agaleridis, Christopher Lai

Registry-linked trialAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07453901 (The Multicentre Prospective Observational Study on the Management of Septic Shock), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07453901 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Multicentre Prospective Observational Study on the Management of Septic Shock (Observational Study on Septic Shock, the OSS Study)

Typeobservational_patient_registrySponsorBicetre HospitalRan2026 to 2028Enrolled5,000ConditionsSeptic Shock
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. [Vasopressors in septic shock: the old and the new].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Vasopressors or fluids for initial resuscitation in septic shock: A matter of clinical judgement.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Clarithromycin for treating sepsis in adults.The Cochrane database of systematic reviews · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Current standard of care for septic shock.Intensive care medicine · 2026
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rui Shi *Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-Sen University, The Emergency and Critical Care Clinical Research Center of Guangdong Province, Guangzhou, Guangdong, China.
Rayan Braïk *AP-HP, Service de Médecine Intensive-Réanimation, Hôpital de Bicêtre, DMU 4 CORREVE, IHU PROMETHEUS, FHU SEPSIS, CARMAS, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Xavier MonnetAP-HP, Service de Médecine Intensive-Réanimation, Hôpital de Bicêtre, DMU 4 CORREVE, IHU PROMETHEUS, FHU SEPSIS, CARMAS, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Wan-Jie GuDepartment of Intensive Care Unit, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Gustavo Ospina-TasconDepartment of Intensive Care Medicine, Fundacion Valle del Lili, Cali, Colombia.
Chairat PermpikulFaculty of Medicine, Division of Critical Care Medicine, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Maxime DjebbourAP-HP, Service de Médecine Intensive-Réanimation, Hôpital de Bicêtre, DMU 4 CORREVE, IHU PROMETHEUS, FHU SEPSIS, CARMAS, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Alice SoumareAP-HP, Service de Médecine Intensive-Réanimation, Hôpital de Bicêtre, DMU 4 CORREVE, IHU PROMETHEUS, FHU SEPSIS, CARMAS, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Vincent AgaleridisAP-HP, Service de Médecine Intensive-Réanimation, Hôpital de Bicêtre, DMU 4 CORREVE, IHU PROMETHEUS, FHU SEPSIS, CARMAS, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Christopher LaiAP-HP, Service de Médecine Intensive-Réanimation, Hôpital de Bicêtre, DMU 4 CORREVE, IHU PROMETHEUS, FHU SEPSIS, CARMAS, Université Paris-Saclay, Le Kremlin-Bicêtre, France. christopher.lai@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe optimal timing for initiating norepinephrine in septic shock is debated. This updated systematic review and meta-analysis aimed to evaluate the impact of early versus delayed norepinephrine initiation on mortality and clinical outcomes in adults with septic shock.

methodsA systematic search in Pubmed, EMbase and the Cochrane Library to identify eligible randomized controlled trials, propensity score matching (PSM) and observational studies that compare early norepinephrine initiation with non-early norepinephrine initiation in patients with acute circulatory failure. The primary outcome was mortality in intensive care unit. Secondary outcomes included intensive care unit length of stay, fluid volume received at 6 h, norepinephrine dose, mechanical ventilation-free days, renal replacement therapy free days, and time to achieve a targeted mean arterial pressure (MAP). Meta-analysis and subgroup analysis were conducted to calculate odds ratio (OR) or mean difference with 95% confidence interval (95%CI) using random-effect model. Trial sequential analysis was conducted to evaluate the conclusiveness of evidence.

resultsTen studies (two RCT, three PSM and five observational studies) involving 4767 patients were included. Early norepinephrine significantly reduced mortality in RCT (OR 0.49, 95%CI 0.25-0.96; I

conclusionEarly norepinephrine introduction in septic shock is associated with reduced mortality, decreased fluid volume administered at 6 h, faster time to achieve MAP target and more mechanical ventilation-free days. However, the trial sequential analysis indicates that further RCT are still needed to confirm these findings.

Indexed as

NorepinephrineShock, SepticHumansIntensive Care UnitsRandomized Controlled Trials as TopicTime FactorsVasoconstrictor AgentsNorepinephrineVasoconstrictor AgentsAcute circulatory failureFluidsHemodynamicTimingVasopressor

Identifiers

PMID40329359
PMCPMC12057179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.